Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Adam J Glawe *Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706.
Emily F Eix *Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706.
Chad J JohnsonDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53706.
Robert ZarnowskiDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53706.
Maisy K AndesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53706.
James LazarcikDepartment of Civil and Environmental Engineering, University of Wisconsin-Madison, Madison, WI 53706.ORCID 0000-0001-8864-9100
Katherine A Henzler-WildmanDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.ORCID 0000-0002-5295-2121
Jeniel E NettDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53706.ORCID 0000-0001-8587-6244
Funding
Molecular Mechanisms of Channels and TransportersR35GM141748 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Katherine Anne Henzler-Wildman · 2021 to 2026
$2.7M
Mechanism(s) of pathogenicity for Candida aurisR01AI145939 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI NETT, JENIEL E · 2020 to 2025
$2.7M
Characterizing Candida auris skin colonization and high-burden biofilm formationR21AI159583 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI NETT, JENIEL E · 2021 to 2022
$427k
HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R01AI145939HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R21AI159583NIGMS NIH HHS R35 GM141748
6 · The paper itself
Abstract
The recently emergent fungal pathogen
Indexed as
Candida aurisCation Transport ProteinsFungal ProteinsPotassiumSkinBiological TransportHumansCation Transport ProteinsFungal ProteinsPotassiumCandida aurisCandidozymacolonizationpotassiumskin
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Trk1 potassium transport is crucial for effective · full record | OpenQuestion